LaunchBio Inc.

🎤  NextGen VC Podcast alert! 🎤 Join hosts Michael Hostetler and Jennifer Fang of Wilson Sonsini Goodrich & Rosati as they are joined by Josep B., president and CEO of NImmune Biopharma, Inc Biopharma and founder of The NIMML Institute, a nonprofit research organization. A scientist turned entrepreneur, Josep shares his journey from academia to launching multiple biotech ventures, including Lando Biopharma (acquired by AbbVie). He reflects on the pivotal moments that led him to leave the university world and build companies at the intersection of science and innovation. We dive into the early stages of company formation, his experiences working with investors like Chris Garabedian and Perceptive Advisors, and why maintaining control over company direction and governance is critical—especially for repeat founders. Josep also shares insights on the future of immunotherapy and the promise of precision medicine in treating autoimmune and inflammatory diseases. Listen here: https://lnkd.in/gRERY2Sk #VentureCapital #HealthcareInnovation #Podcast #LifeSciences #WSLifeSci #BuildingBetterBiotechs

Meet the next wave of biotech innovators. HiveBio.io is unveiling its first-ever cohort on May 29 in a special webinar. Join us! https://lnkd.in/drnSA2aN

2 days away! Don't miss insights from Jody K. Thelander and Morgan Thelander of J. Thelander Consulting. Sign up to secure your spot.

LaunchBio is back in NC on June 5 for Built to Scale: Building a Strong "People" Foudnation for Your LIfe Science Startup. Join us in RTP for practical insights and relaxed networking designed for biotech entrepreneurs and early-stage teams. Enjoy cold craft beer on tap from Flying Bull Beer Company and a delicious meal from the Bulgogi Food Truck. Space is limited, so register today! https://lnkd.in/enScFp9K Together with Longfellow Real Estate Partners and OneDigital

During Session 3 of our upcoming NextGen VC Forum, Wilson Sonsini Goodrich & Rosati's Laurie McNamara and Alex Key along with OrbiMed's Ran Geng will address the legal playbook for biotech spinouts. Laurie, Alex, and Ran will offer real-world insights on market entry, navigating evolving policies, and mitigating risks while maximizing value. Whether you're considering a China strategy or have already launched a Spinco, this discussion will equip you with the knowledge to navigate cross-border expansion with confidence. The NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. Space is limited; learn more and request an invite here: https://lnkd.in/ge7Wd7mM In partnership with Wilson Sonsini Goodrich & Rosati

During Session 2 of our upcoming NextGen VC Forum, Wilson Sonsini Goodrich & Rosati's Stephen Heifetz and Alicia Umpierre will explore how biotech companies and investors face a growing national seucirty regulatory thicket. Stephen and Alicia will provide an overview of the key regulations shaping the biotech investment landscape and offer practical guidance on how to navigate these challenges. The NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. Space is limited; learn more and request an invite here: https://lnkd.in/ge7Wd7mM In partnership with Wilson Sonsini Goodrich & Rosati

One week away! Register to join our annual Compensation Confidential webinar, where Jody K. Thelander and Morgan Thelander of J. Thelander Consulting will share real-time data on base salaries, actual and target bonuses, founder and non-founder equity and more. Gain practical insights to help structure competitive packages and retain top talent. Learn more and register here: https://lnkd.in/exY3c7G5

During Session 1 of our upcoming NextGen VC Forum, Wilson Sonsini Goodrich & Rosati's Scott McKinney and Nellie J. Brutocao will explore biotech, AI, and the law. Scott and Nellie will examine the evolving legal framework for AI-driven biotech companies, covering key topics such as intellectual property, data privacy, regulatory compliance, liability risks, and more. Industry experts will offer practical guidance on managing legal risks, navigating regulatory hurdles, attracting investment, and aligning AI solutions with biotech standards. Gain the insights you need to protect your AI investments. This is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. Space is limited; learn more and request an invite here: https://lnkd.in/ge7Wd7mM In partnership with Wilson Sonsini Goodrich & Rosati

Our May Investor Connect virtual program features Luma Group, an early-stage venture capital fund that invests in therapeutic, diagnostic, and medical device companies from Seed through Series B. Luma has a technology-first investment thesis and invests primarily in platform companies developing first-in-class or best-in-class assets. They partner with visionary founders to build transformative companies, not just by investing capital, but by sharing deep industry expertise, strategic guidance, and a strong network to help them grow and scale. Learn more and apply here: https://lnkd.in/eKqxPgiC Together with Browne Consulting and Silicon Valley Bank

Welcome, Natalia! We are pleased to introduce LaunchBio's summer intern, Natalia Relic, to our community. Natalia is based out of San Diego and is currently pursuing a Master’s in Biotechnology Enterprise and Entrepreneurship through Johns Hopkins University online program. She holds a B.S. in Global Health from UC San Diego. She first got connected with LaunchBio when she attended our February Invest in Cures forum.